RxDoctor Payments Data

Bhuvaneswari Ramaswamy

Medical Oncology · Columbus, OHNPI 1851348098

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $1,875 of the $2,012 with a category attached, or 93.2%. Eisai Inc. accounts for 99.4% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for medical oncology clinicians in OH, where the typical reported total is $2,659.

$2,012in general payments, 2019–2025

Across 3 payments — averaging $670.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eisai Inc.$2K
  • Gilead$12
$1,037,466in research payments, 2019–2025

Across 34 payments — averaging $30,514 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$1M
  • Novartis$30K
  • Astrazeneca UK Limited$6K

What the payments were for

  • Consulting fees$1,87593%
  • Food & beverage$1256%
  • Education$121%

General payments by program year

19
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eisai Inc.2$2,000
Gilead1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,012 in reported general payments places this provider in the 45th percentile of 157 medical oncology providers in Ohio.

See all medical oncology providers in Ohio

Other medical oncology in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →